TrialAmerican journal of hematology2022

Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.

Yawen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.